Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Oncology - Page 7

Oncology

Siteman Cancer Center to offer newest form of proton therapy
Biotechnology | Medical Device | Non-Profit Research | Oncology

Siteman Cancer Center to offer newest form of proton therapy

On Oct. 22, 2018, the Siteman Cancer Center announced a second proton therapy system that would incorporate pencil-beam…

Read More Siteman Cancer Center to offer newest form of proton therapyContinue

The Cancer Prevention and Research Institute announced the formation of the 2018 Texas Cancer Plan
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Therapeutics

The Cancer Prevention and Research Institute announced the formation of the 2018 Texas Cancer Plan

On Sept. 25, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the formation of the…

Read More The Cancer Prevention and Research Institute announced the formation of the 2018 Texas Cancer PlanContinue

The Cancer Prevention and Research Institute of Texas announced surpassed $2 billion in grants to fight cancer
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Therapeutics | Women's Health

The Cancer Prevention and Research Institute of Texas announced surpassed $2 billion in grants to fight cancer

On Aug. 24, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it passed a $2…

Read More The Cancer Prevention and Research Institute of Texas announced surpassed $2 billion in grants to fight cancerContinue

Texas Life Science Genealogy, 2018
Agriculture | Biotechnology | Diagnostics | Disease | Life Science History | Medical Device | Oncology | Pharmaceutical | Veterinary

Texas Life Science Genealogy, 2018

Texas Life Science Genealogy illustrates life science companies and non-profit research organization in the State of Texas by…

Read More Texas Life Science Genealogy, 2018Continue

Karmanos Cancer Institute began renovations to expand services in Farmington Hills
Biotechnology | Diagnostics | Oncology | Radiology | Therapeutics

Karmanos Cancer Institute began renovations to expand services in Farmington Hills

On May 18, 2018, The Barbara Ann Karmanos Cancer Institute announced it will expand its Lawrence and Idell…

Read More Karmanos Cancer Institute began renovations to expand services in Farmington HillsContinue

National Cancer Institute scientists reported low-dose drug combination cuts risk of colon polyp recurrence
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics

National Cancer Institute scientists reported low-dose drug combination cuts risk of colon polyp recurrence

May 4, 2018, scientists from the National Cancer Institute (NCI) reported that an analysis of a prevention clinical…

Read More National Cancer Institute scientists reported low-dose drug combination cuts risk of colon polyp recurrenceContinue

The CPRIT announced a Seed Award for early-stage oncology startup companies
Biotechnology | Diagnostics | Disease | Oncology | Therapeutics

The CPRIT announced a Seed Award for early-stage oncology startup companies

On Apr. 30, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced a Seed Award for…

Read More The CPRIT announced a Seed Award for early-stage oncology startup companiesContinue

Seattle Genetics acquired Cascadian Therapeutics
Biotechnology | Disease | Oncology | Therapeutics

Seattle Genetics acquired Cascadian Therapeutics

On Mar. 9, 2018, Seattle Genetics announced it had completed its acquisition of Cascadian Therapeutics for approximately $614…

Read More Seattle Genetics acquired Cascadian TherapeuticsContinue

FDA authorized direct-to-consumer test that reports three mutations in the BRCA breast cancer genes
Biotechnology | Diagnostics | Disease | Oncology | Therapeutics

FDA authorized direct-to-consumer test that reports three mutations in the BRCA breast cancer genes

On Mar. 6, 2018, the U.S. Food and Drug Administration authorized 23andMe’s Personal Genome Service Genetic Health Risk…

Read More FDA authorized direct-to-consumer test that reports three mutations in the BRCA breast cancer genesContinue

The University of Michigan Cancer Center was renamed the Rogel Cancer Center
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Therapeutics

The University of Michigan Cancer Center was renamed the Rogel Cancer Center

In 2018, the University of Michigan Cancer Center was renamed the Rogel Cancer Center in recognition of a…

Read More The University of Michigan Cancer Center was renamed the Rogel Cancer CenterContinue

FDA approved first biosimilar for the treatment of certain breast and stomach cancers
Biotechnology | Disease | FDA | Oncology | Therapeutics

FDA approved first biosimilar for the treatment of certain breast and stomach cancers

On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…

Read More FDA approved first biosimilar for the treatment of certain breast and stomach cancersContinue

Siteman Cancer Center became one of the first cancer centers nationwide to offer newly approved CAR-T cell therapy called Yescarta
Biotechnology | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics

Siteman Cancer Center became one of the first cancer centers nationwide to offer newly approved CAR-T cell therapy called Yescarta

On Oct. 18, 2017, the Siteman Cancer Center became one of the first cancer centers nationwide to offer…

Read More Siteman Cancer Center became one of the first cancer centers nationwide to offer newly approved CAR-T cell therapy called YescartaContinue

Emory University selected by National Cancer Institute (NCI) for participation in elite national network for cancer therapeutic discovery
Biotechnology | NIH | Oncology | Therapeutics

Emory University selected by National Cancer Institute (NCI) for participation in elite national network for cancer therapeutic discovery

On Oct. 2, 2017, Emory University was selected by the National Cancer Institute (NCI) for participation in an…

Read More Emory University selected by National Cancer Institute (NCI) for participation in elite national network for cancer therapeutic discoveryContinue

The CPRIT awarded 60 grants totaling more than $102 million
Biotechnology | Disease | Non-Profit Research | Oncology | Therapeutics

The CPRIT awarded 60 grants totaling more than $102 million

On Aug. 16, 2017, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 60 new academic research,…

Read More The CPRIT awarded 60 grants totaling more than $102 millionContinue

NIH selected OHSU Knight Cancer Institute to co-lead largest national database for pediatric cancer, rare disease research
Biotechnology | Diagnostics | NIH | Non-Profit Research | Oncology

NIH selected OHSU Knight Cancer Institute to co-lead largest national database for pediatric cancer, rare disease research

On Aug. 15, 2017, the National Institutes of Health’s (NIH) Gabriella Miller Kids First Pediatric Research Program awarded…

Read More NIH selected OHSU Knight Cancer Institute to co-lead largest national database for pediatric cancer, rare disease researchContinue

National Cancer Institute awarded Fred Hutch $24 million to operate Contact Center for patients
Biotechnology | Diagnostics | Medicine | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics

National Cancer Institute awarded Fred Hutch $24 million to operate Contact Center for patients

On May 24, 2017, the National Cancer Institute (NCI) awarded $24 million to Fred Hutchinson Cancer Research Center…

Read More National Cancer Institute awarded Fred Hutch $24 million to operate Contact Center for patientsContinue

Siteman Cancer Center met the standards of the American Society for Radiation Oncology Accreditation Program for Excellence
Biotechnology | Disease | Medical Device | Non-Profit Research | Oncology

Siteman Cancer Center met the standards of the American Society for Radiation Oncology Accreditation Program for Excellence

On May 10, 2017, Siteman Cancer Center met the standards of the American Society for Radiation Oncology (ASTRO)…

Read More Siteman Cancer Center met the standards of the American Society for Radiation Oncology Accreditation Program for ExcellenceContinue

Bezos family donated $35 million to Fred Hutch
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Therapeutics

Bezos family donated $35 million to Fred Hutch

On Mar. 30, 2017, the Fred Hutchinson Cancer Research Center announced that the Bezos family had donated $35…

Read More Bezos family donated $35 million to Fred HutchContinue

Celgene, Dana-Farber, and University of Arkansas established the Myeloma Genome Project
Biotechnology | Diagnostics | Disease | Genomics | Medicine | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics

Celgene, Dana-Farber, and University of Arkansas established the Myeloma Genome Project

On Dec. 3, 2016, Celgene, Dana-Farber Cancer Institute and the University of Arkansas for Medical Sciences announced the…

Read More Celgene, Dana-Farber, and University of Arkansas established the Myeloma Genome ProjectContinue

Roswell Park study brought Cuban lung cancer vaccine to U.S. Patients
Biotechnology | FDA | Non-Profit Research | Oncology | Vaccine

Roswell Park study brought Cuban lung cancer vaccine to U.S. Patients

On Oct. 27, 2016, Roswell Park Cancer Institute announced it had received authorization from the U.S. Food and…

Read More Roswell Park study brought Cuban lung cancer vaccine to U.S. PatientsContinue

Genentech drug Tecentriq (atezolizumab) was approved
Biotechnology | Chemical | Disease | FDA | Oncology | Therapeutics

Genentech drug Tecentriq (atezolizumab) was approved

On Oct. 18, 2016, the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of…

Read More Genentech drug Tecentriq (atezolizumab) was approvedContinue

UO launched $1 billion Phil and Penny Knight Campus for Accelerating Scientific Impact
Biotechnology | Non-Profit Research | Oncology | Therapeutics

UO launched $1 billion Phil and Penny Knight Campus for Accelerating Scientific Impact

On Oct. 18, 2016, the University of Oregon (UO) announced the $1 billion Phil and Penny Knight Campus…

Read More UO launched $1 billion Phil and Penny Knight Campus for Accelerating Scientific ImpactContinue

New prostate cancer therapy investigated at Vanderbilt University Medical Center
Biotechnology | Oncology | Therapeutics

New prostate cancer therapy investigated at Vanderbilt University Medical Center

On Sept. 22, 2016, Vanderbilt University Medical Center became the world’s first site to treat a prostate cancer…

Read More New prostate cancer therapy investigated at Vanderbilt University Medical CenterContinue

Siteman Cancer Center received a $10.4 million  grant from the NCI
Biotechnology | Non-Profit Research | Oncology | Therapeutics | Vaccine

Siteman Cancer Center received a $10.4 million grant from the NCI

On Aug. 15, 2016, Siteman Cancer Center received a $10.4 million five-year grant to Washington University researchers and…

Read More Siteman Cancer Center received a $10.4 million grant from the NCIContinue

SERM drug raloxifene (Evista) found to reduce breast cancer risk for postmenopausal women
Biotechnology | Disease | Oncology | Therapeutics

SERM drug raloxifene (Evista) found to reduce breast cancer risk for postmenopausal women

On Jul. 17, 2006, the SERM drug raloxifene (Evista) was found to reduce breast cancer risk for postmenopausal…

Read More SERM drug raloxifene (Evista) found to reduce breast cancer risk for postmenopausal womenContinue

The Stanford Cancer Institute became a NCI Designated Comprehensive Cancer Center
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Radiology | Therapeutics

The Stanford Cancer Institute became a NCI Designated Comprehensive Cancer Center

On Jul. 5, 2016, The Stanford Cancer Institute announced it had been designated a Comprehensive Cancer Center by…

Read More The Stanford Cancer Institute became a NCI Designated Comprehensive Cancer CenterContinue

University of Michigan Board of Regents announced a $17.5 million commitment for cancer research from Madeline and Sidney Forbes
Biotechnology | Disease | Non-Profit Research | Oncology | Therapeutics

University of Michigan Board of Regents announced a $17.5 million commitment for cancer research from Madeline and Sidney Forbes

On Jun. 16, 2016, The University of Michigan Board of Regents announced a $17.5 million commitment for cancer…

Read More University of Michigan Board of Regents announced a $17.5 million commitment for cancer research from Madeline and Sidney ForbesContinue

Mary-Claire King was awarded the National Medal of Science
Biotechnology | Genomics | Non-Profit Research | Oncology

Mary-Claire King was awarded the National Medal of Science

On May 19, 2016, President Barack Obama presented Mary-Claire King, Ph.D., a University of Washington professor of medicine…

Read More Mary-Claire King was awarded the National Medal of ScienceContinue

$200 million gift launched the Lawrence J. Ellison Institute for Transformative Medicine of USC
Biotechnology | Disease | Medicine | Non-Profit Research | Oncology | Therapeutics

$200 million gift launched the Lawrence J. Ellison Institute for Transformative Medicine of USC

On May 12, 2016, technology entrepreneur and founder of Oracle, Larry Ellison announced the donation $200 million to…

Read More $200 million gift launched the Lawrence J. Ellison Institute for Transformative Medicine of USCContinue

A team of OMRF researchers led by Gary Gorbsky found a way to turn back cell division
Biotechnology | Disease | Non-Profit Research | Oncology | Therapeutics

A team of OMRF researchers led by Gary Gorbsky found a way to turn back cell division

On Apr. 18, 2016, a team of Oklahoma Medical Research Foundation (OMRF) researchers led by Gary Gorbsky found…

Read More A team of OMRF researchers led by Gary Gorbsky found a way to turn back cell divisionContinue

Page navigation

Previous PagePrevious 1 … 5 6 7 8 9 … 26 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search